| Financial Year |
September 30 2020 |
| Monetary Funds |
5,459,104.81 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
400,634,634.62 |
| Advances to Suppliers |
4,761,056.17 |
| Other Receivables |
8,450,441.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
8,464,430,947.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
256,299.84 |
| Other Current Assets |
35,063,421.39 |
| Total Current Assets |
8,919,055,905.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
136,366,814.46 |
| Fixed Assetes |
124,715,158.38 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
41,028,819.82 |
| R&D expenses |
-- |
| Goodwill |
7,955,050.10 |
| Long-Term Deferred and Prepaid Expenses |
1,311,068.07 |
| Deferred Income Tax Assets |
893,550,579.35 |
| Other Non-Current Assets |
254,222,400.00 |
| Sub-Total of Non-Current Assets |
1,844,474,890.18 |
| Total Assets |
10,763,530,795.72 |
| Short-Term Loans |
1,048,959,828.20 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
77,724,310.56 |
| Accounts Received In Advance |
115,435.66 |
| Employee Compensation Payable |
53,539,893.98 |
| Taxes Payable |
133,642,589.23 |
| Interest Payable |
2,192,316,188.05 |
| Dividend Payable |
7,797.38 |
| Other payables |
3,301,768,039.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,985,493,347.22 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
9,620,528,798.94 |
| Long-term Loans |
-- |
| Bonds Payable |
747,739,911.81 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
700,382,502.82 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,448,122,414.63 |
| Total Liabilities |
11,068,651,213.57 |
| Paid-In Capital(Or Share Stock) |
1,350,000,000.00 |
| Capital Surplus |
1,313,049,873.65 |
| Surplus Reserve |
44,997,224.66 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,031,988,428.96 |
| Minority Stockholder's Interest |
18,820,912.80 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-323,941,330.65 |
| Owner's Equity（Stockholder's Equity） |
-305,120,417.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,763,530,795.72 |
